Page last updated: 2024-08-25

stearoyl alpha-lysolecithin and Arteriosclerosis

stearoyl alpha-lysolecithin has been researched along with Arteriosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Higuchi, S; Ichikawa, K; Iida, M; Iino, K; Iwase, M; Ohdo, S; Sonoki, K; Yoshinari, M	1

Other Studies

1 other study(ies) available for stearoyl alpha-lysolecithin and Arteriosclerosis

Article	Year
Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. Metabolism: clinical and experimental, 2003, Volume: 52, Issue:3 Topics: Arteriosclerosis; Chemokine CCL2; Diabetes Mellitus, Type 2; DNA; Endothelium, Vascular; Gene Expression; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; NF-kappa B; Nitric Oxide Donors; Nitro Compounds; Phospholipases A; Phospholipases A2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Umbilical Veins	2003

Article

Year

Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor.

Metabolism: clinical and experimental, 2003, Volume: 52, Issue:3

Topics: Arteriosclerosis; Chemokine CCL2; Diabetes Mellitus, Type 2; DNA; Endothelium, Vascular; Gene Expression; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; NF-kappa B; Nitric Oxide Donors; Nitro Compounds; Phospholipases A; Phospholipases A2; RNA, Messenger; Thiobarbituric Acid Reactive Substances; Umbilical Veins

2003